BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 181689)

  • 1. Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
    Gumulka SW; Dinnendahl V; Peters HD; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):75-80. PubMed ID: 181689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic stimulants and cyclic nucleotides in mouse brain. Effects of dopaminergic antagonists, cholinolytics, and GABA agonists.
    Gumulka SW; Dinnendahl V; Schönhöfer PS; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):21-6. PubMed ID: 187962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of circling models for the detection of antiparkinson activity.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975; 41(1):57-64. PubMed ID: 1091939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
    Uemura H
    Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
    Kuschinsky K
    Psychopharmacologia; 1975 Jun; 42(3):225-9. PubMed ID: 1172252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
    Cox B; Kastin AJ; Schnieden H
    Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.
    Duterte-Boucher D; Costentin J
    Psychopharmacology (Berl); 1989; 98(1):56-60. PubMed ID: 2543019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
    Cox B; Tha SJ
    Eur J Pharmacol; 1973 Oct; 24(1):96-100. PubMed ID: 4796449
    [No Abstract]   [Full Text] [Related]  

  • 14. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Lazarova MB; Roussinov KS
    Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
    Bailey R; Crisp E; Jackson DM; Jenkins O
    J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomifensine: a potent dopaminergic agonist of antiparkinson potential.
    Costall B; Kelly DM; Naylor RJ
    Psychopharmacologia; 1975; 41(2):153-64. PubMed ID: 1098084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of L-histidine and promethazine on apomorphine and amantadine stereotypy in rats.
    Balsara JJ; Dhavare BS; Nandal NV; Chandorkar AG
    Psychopharmacology (Berl); 1983; 79(4):372-4. PubMed ID: 6407056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
    Buckett WR; Shaw JS
    Psychopharmacologia; 1975 Jun; 42(3):293-7. PubMed ID: 1172254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.